Novartis pauses autoimmune cell therapy studies after deaths
Novartis suspends eight CAR-T autoimmune and neurological trials after three deaths, launches safety review and works with regulators, WSJ reports
Reuters1 min read
Share

File photo
Add Emirates 24|7 to your Google News
Text Size:
